Longfellow Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

Longfellow Investment Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,385	Closed	-$36K	–	365
2022 Q3	$36K	Buy	+2,385	New	+$27.7K	0.01%	236

Longfellow Investment Management's AERI Position: Q4 2022 in Review

Longfellow Investment Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 2,385 shares — an estimated $36K sold.

Longfellow Investment Management first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $36K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Longfellow Investment Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Longfellow Investment Management sold 2,385 Aerie Pharmaceuticals shares in Q4 2022, an estimated $36K.
Longfellow Investment Management first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
Longfellow Investment Management's Aerie Pharmaceuticals position peaked at $36K in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Longfellow Investment Management's 13F filing for Q4 2022, filed 9 Feb 2023.